Abstract
This article explores the groundbreaking application of mRNA vaccines in cancer treatment. It begins with an indepth examination of mRNA vaccines, elucidating their fundamental components and role in vaccine development. The discussion then pivots to transitioning mRNA vaccine technology into cancer therapy, highlighting potential advantages, such as personalized medicine, targeted therapy, and reduced side effects. Promising examples of mRNA vaccines in development for various cancer types, including melanoma and solid tumors, are discussed. However, it is crucial to acknowledge the challenges and limitations associated with this innovative approach, such as immunogenicity concerns, manufacturing scalability, ethical considerations, regulatory approval, and logistical hurdles. Despite these challenges, mRNA vaccines offer a transformative potential to revolutionize cancer therapy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
